✦ LIBER ✦

On the Optimal Allocation of Two or More Treatments in a Controlled Clinical Trial

✍ Scribed by K. D. Glazebrook

Book ID: 124280030
Publisher: Oxford University Press
Year: 1978
Tongue: English
Weight: 656 KB
Volume: 65
Category: Article
ISSN: 0006-3444
DOI: 10.2307/2335212

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discussion of 'On the Allocation of Trea

Discussion of 'On the Allocation of Treatments in Sequential Medical Trials' by J.A. Bather and 'The Search for Optimality in Clinical Trials' by P. Armitage

✍ G. A. Barnard 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Discussion of 'On the Allocation of Trea

Discussion of 'On the Allocation of Treatments in Sequential Medical Trials' by J.A. Bather and 'The Search for Optimality in Clinical Trials' by P. Armitage

✍ Herman Chernoff 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Discussion of 'On the Allocation of Trea

Discussion of 'On the Allocation of Treatments in Sequential Medical Trials' by J.A. Bather and 'The Search for Optimality in Clinical Trials' by P. Armitage

✍ Thomas A. Louis 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

Discussion of 'On the Allocation of Trea

Discussion of 'On the Allocation of Treatments in Sequential Medical Trials' by J.A. Bather and 'The Search for Optimality in Clinical Trials' by P. Armitage

✍ Richard Peto 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Discussion of 'On the Allocation of Trea

Discussion of 'On the Allocation of Treatments in Sequential Medical Trials' by J.A. Bather and 'The Search for Optimality in Clinical Trials' by P. Armitage

✍ John Whitehead 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

A program for balancing the allocation o

A program for balancing the allocation of subjects to treatment in a clinical trial

✍ Mikel Aickin 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Minimum likelihood allocation (MLA) is a new method for sequentially assigning subjects to treatment groups in a clinical trial. Its aim is to balance the trial, that is, to prevent various treatment groups from containing subjects who have much better or much worse prognoses than the average. The o